XXII 22nd Century Group Inc.

22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

  • CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century Group
  • Integration of GVB Biopharma Proceeding at a Rapid Pace

BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company), dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the appointment of R. Hugh Kinsman as Chief Financial Officer. Kinsman is currently CFO of GVB Biopharma, which 22nd Century acquired effective May 13, 2022.

“The integration of GVB Biopharma is proceeding very well, and we are excited to build on Hugh’s success at GVB by elevating his financial leadership role to 22nd Century as a whole,” said James A. Mish, chief executive officer of 22nd Century Group. “Hugh brings extensive executive finance experience in fast growing public companies, as we work to advance our corporate strategies in tobacco and expand the breadth and scale of our hemp/cannabis franchise. This includes the launch of our VLN® reduced nicotine content cigarettes in the U.S. and the addition of GVB’s industry leading extraction and white label capabilities to our existing upstream hemp/cannabis development programs. We believe that 22nd Century is now positioned to play a leading role in future growth markets focused on tobacco harm reduction and improved utilization of hemp/cannabis derived products offering health and wellness benefits to consumers by scaling these franchises to achieve scale and operating leverage.”

Mr. Kinsman has extensive experience as a senior executive in roles ranging from acting CFO of a publicly-traded battery manufacturer with operations in the U.S., Switzerland, and Italy to the CFO of West World Media, a private data aggregation company that was acquired for $60 million. He also worked at GE Capital where he oversaw over a billion dollars in infrastructure, energy, and communications investments. He began his career at Asher & Company, CPAs (now BDO) and has held a Certified Public Accountant designation. He earned his B.S. in Finance from Penn State University and his MBA from Cornell University.

About 22nd Century Group, Inc.

22nd Century Group, Inc. (Nasdaq: ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the  to address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.

Learn more at , on , on , and on .

Cautionary Note Regarding Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 11, 2021. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact:

Mei Kuo

22nd Century Group, Inc.

Director, Communications & Investor Relations

T: 716-300-1221

Darrow Associates Investor Relations

Matt Kreps

T: 214-597-8200



EN
16/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 22nd Century Group Inc.

 PRESS RELEASE

22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributin...

22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing Company to Place VLN® in Thousands of Retail Locations Across Colorado Partnership Will Bring Reduced Nicotine Content Cigarettes to New Regional and National Chains and Independent Accounts StatewideEagle Rock Is a Wholesaler for Anheuser-Busch With Deep Expertise In the Colorado Retail Market BUFFALO, N.Y., Sept. 20, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced ...

 PRESS RELEASE

22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicot...

22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden’s Cancer Moonshot Initiative Aligned with FDA and Biden Administration Important Initiative to Limit Nicotine Content in Cigarettes and Ban MentholVLN® Reduced Nicotine Content Cigarettes Are Designed Specifically to “” and Reduce Exposure to Activities Known to Cause CancerExceptional Pilot Results in Chicago Lead to Expanding VLN® Points of Sale in Chicago and State of Illinois BUFFALO, N.Y., Sept. 13, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading agric...

 PRESS RELEASE

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executiv...

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board Pioneer Entertainment Executive to Extend Digital Media Expertise to Company’s Mission in Tobacco Harm Reduction and Raise Profile in Hemp/Cannabis Industry BUFFALO, N.Y., Sept. 12, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced the appointment of Lucie S. Salhany to its Board of Directors. Ms. Sal...

 PRESS RELEASE

22nd Century Group (Nasdaq: XXII) Announces Management Updates and Dep...

22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer BUFFALO, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced changes in its management team as the Company accelerates growth in its reduced nicotine content tobacco business. The Company announced that Michael Zercher, President and Chief Operating Officer, will depart the Company effecti...

 PRESS RELEASE

22nd Century Group (Nasdaq: XXII) Launches VLN® Reduced Nicotine Conte...

22nd Century Group (Nasdaq: XXII) Launches VLN® Reduced Nicotine Content Cigarettes in Colorado with Circle K, Smoker Friendly and New Distribution Points Two Additional Distribution Partnerships Will Target Thousands of Additional Colorado Retail StoresStrong Pilot Results Lead to Expanding VLN® Points of Sale in Chicago and the State of Illinois BUFFALO, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced p...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch